Skip to main content

BBS-Bioactive Bone Substitutes Plc: Managers’ Transactions

Written by Customer Service on . Posted in Public Companies.


Person subject to the notification requirement
Name: Pekka Jalovaara
Position: Member of the Board/Deputy member
(X) Legal person
Issuer: BBS-Bioactive Bone Substitutes OYJ
LEI: 743700BYSBP0PCR6N767Notification type: INITIAL NOTIFICATION
Reference number: 743700BYSBP0PCR6N767_20200623141255_9
____________________________________________Transaction date: 2020-06-18
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
ISIN: FI4000440219
Instrument name: BBS-Bioactive Bone Substitutes OYj osakkeen merkintäoikeus
Nature of the transaction: DISPOSAL
(X) Executed under portfolio or asset managementTransaction details
(1): Volume: 461,450 Unit price: .216 EURAggregated transactions
(1): Volume: 461,450 Volume weighted average price: .216 EUR
____________________________________________Transaction date: 2020-06-18
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000260583
Nature of the transaction: ACQUISITION
(X) Executed under portfolio or asset managementTransaction details
(1): Volume: 17,000 Unit price: 4.2 EURAggregated transactions
(1): Volume: 17,000 Volume weighted average price: 4.2 EUR
____________________________________________
Person subject to the notification requirement
Name: Jarmo Halonen
Position: Member of the Board/Deputy member
(X) Legal person
Issuer: BBS-Bioactive Bone Substitutes OYJ
LEI: 743700BYSBP0PCR6N767Notification type: INITIAL NOTIFICATION
Reference number: 743700BYSBP0PCR6N767_20200625170441_3
____________________________________________Transaction date: 2020-06-18
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000260583
Nature of the transaction: ACQUISITIONTransaction details
(1): Volume: 14,719 Unit price: 4.2 EUR
(2): Volume: NaN Unit price: NaN EURAggregated transactions
(2): Volume: 14,719 Volume weighted average price: 4.2 EUR____________________________________________
Person subject to the notification requirement
Name: Oili Halonen
Position: Closely associated person
(X) Legal person(1):Person Discharging Managerial Responsibilities In Issuer
Name: Jarmo Halonen
Position: Member of the BoardIssuer: BBS-Bioactive Bone Substitutes OYJ
LEI: 743700BYSBP0PCR6N767Notification type: INITIAL NOTIFICATION
Reference number: 743700BYSBP0PCR6N767_20200625170844_2
____________________________________________Transaction date: 2020-06-18
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000260583
Nature of the transaction: ACQUISITIONTransaction details
(1): Volume: 4,751 Unit price: 4.2 EURAggregated transactions
(1): Volume: 4,751 Volume weighted average price: 4.2 EUR

BBS-BIOACTIVE BONE SUBSTITUTES PLCFor more information:CEO Ilkka KangasniemiPhone: +358 40 7080307E-mail: ilkka.kangasniemi@bbs-artebone.fiThis is information that BBS-Bioactive Bone Substitutes Plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on 25 June 2020 at 8:15 pm (UTC +3.00).About BBSBBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. Our mission is to offer new generation medicinal products for the orthopedic surgery. The research and development in the field of medicine requires perseverance and courage to develop new things.  We have over 20 years of expertise in this. Our operations are characterised by top expertise, innovativeness and dedicated and committed employees. The first product, ARTEBONE® Paste, is ready and the application process for the CE-marking enabling commercialization is in progress. More information: www.bbs-artebone.fi.BBS-Bioactive Bone Substitutes Plc shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden. The company’s Certified Adviser is Stockholm Certified Advisers AB, p. +46 70 5516 729, info@certifiedadviser.se

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.